ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 71. Num. 7.
Pages 588-590 (July 2018)

Scientific letter
Out-of-working-hours Primary Percutaneous Coronary Intervention in STEACS: Does It Worsen Clinical Outcomes?

Intervención coronaria percutánea primaria en el SCACEST fuera del horario laboral. ¿Tiene peores resultados clínicos?

Aída Escudero-GonzálezXacobe Flores-RíosCayetana Barbeito-CaamañoPatricia Pardo-MartínezNicolás Vázquez-GonzálezJosé M. Vázquez Rodríguez

Options

To the Editor,

There are no studies in Spain investigating the outcome of primary percutaneous interventions (PPCIs) for ST-elevation acute coronary syndrome (STEACS) performed out-of-working-hours (OWH) compared with those carried out during working hours (WH).

A retrospective analysis was performed in a cohort of STEACS patients treated by PPCI in our center between 2006 and 2014 (N = 2941). The characteristics of the sample were obtained from the center's electronic database, where patient information is prospectively recorded by the physician performing the procedure. PPCI was established as being OWH when it was performed on weekdays between 3:00 p.m. and 8:00 a.m., on weekends, or on official holidays, whereas WH PPCIs were procedures carried out on weekdays between 8:00 a.m. and 3:00 p.m.

The main event evaluated was death during follow-up. Secondary events were reinfarction, revascularization of the treated vessel, and demonstrated stent thrombosis. The electronic medical records (IANUS software) were exhaustively reviewed to estimate clinical event rates using the Kaplan-Meier method; comparisons were made with the log-rank test. Cox regression analysis was applied to assess the effect of OWH PPCI on mortality adjusted by age, sex, diabetes mellitus, previous acute myocardial infarction, creatinine clearance, hemoglobin, anterior SCACEST, Killip class, left ventricular ejection fraction, multivessel disease, radial access, total ischemia time, and the success of PPCI.

In total, 2185 OWH PPCI (74.3%) were performed. There were no differences between OWH and WH procedures with regard to the patients’ clinical or angiographic characteristics, or procedure-related factors (Table 1). PPCI success rates were similar between the 2 groups (OWH 95.2% and WH 95.1%; P = .921).

Table 1.

Baseline and Procedure-Related Characteristics

  PPCI WH (n = 756)  PPCI OWH (n = 2185)  P 
Cardiovascular risk factors
Age, y  63.6 (13.03)  62.7 (13.07)  .106 
Women  177 (23.4)  453 (20.7)  .123 
Hypertension  358 (47.4)  1037 (47.5)  .966 
Diabetes mellitus  151 (20.0)  409 (18.7)  .452 
Smoker  260 (34.4)  870 (39.8)  .008 
Dyslipidemia  304 (40.2)  887 (40.6)  .864 
Medical history
Previous infarction  69 (9.1)  190 (8.7)  .710 
Previous PCI  67 (8.9)  187 (8.6)  .822 
Coronary surgery  8 (1.1)  20 (0.9)  .670 
Stroke/TIA  18 (2.4)  62 (2.8)  .604 
COPD  14 (1.9)  46 (2.1)  .766 
CrCl  85.9 (37.5)  86.1 (36.1)  .910 
Initial Hb  14.1 (2.44)  14.2 (2.65)  .280 
Type of STEACS
Anterior  325 (43.0)  923 (42.2)  .733 
Inferior  359 (47.5)  1096 (50.2)  .206 
Lateral  43 (5.7)  116 (5.3)  .709 
Posterior  13 (1.7)  29 (1.3)  .477 
Indeterminate  10 (1.3)  14 (0.6)  .097 
Clinical presentation
Shock at presentation  15 (2.0)  53 (2.4)  .575 
PCR at presentation  17 (2.2)  47 (2.2)  .885 
SAP, mmHg  121.6 (23.7)  122.4 (23.6)  .452 
DAP, mmHg  75.4 (14.2)  75.5 (14.0)  .070 
HR, bpm  76.2 (18.5)  76.0 (18.2)  .851 
Medical contact
Medical emergency number-061  153 (20.2)  439 (20.1)  .958 
Nonhospital emergency service  286 (37.8)  872 (39.9)  .321 
Hospital, no catheterization laboratory  124 (16.5)  449 (20.5)  < .001 
Hospital, catheterization laboratory  193 (25.5)  425 (19.5)  < .001 
Killip class at admittance
I  620 (82.0)  1802 (82.5)  .782 
II  46 (6.1)  161 (7.4)  .249 
III  25 (3.3)  49 (2.2)  .108 
IV  65 (8.6)  173 (7.9)  .588 
Coronary disease and ventricular function
Culprit artery
LMCA  6 (0.8)  16 (0.7)  .810 
LAD  333 (44.0)  939 (43.0)  .610 
CX  82 (10.8)  268 (12.3)  .328 
RC  299 (839.6)  900 (41.2)  .440 
Coronary disease
Multivessel disease  371 (49.1)  1.081 (49.5)  .899 
LMCA  30 (4.0)  74 (3.4)  .493 
LAD  523 (69.2)  1459 (66.8)  .242 
CX  289 (38.2)  913 (41.8)  .094 
RC  468 (61.9)  1326 (60.7)  .574 
LVEF, %  54.6 (13.0)  54.6 (12.9)  .983 
LVEF <35%  72 (10.6)  207 (10.0)  .715 
Procedure
Radial access  646 (85.4)  1894 (86.7)  .390 
DES  137 (18.2)  400 (18.3) 
CS  554 (73.8)  1598 (73.3)  .811 
Successful PPCI  719 (95.1)  2081 (95.2)  .921 

COPD, chronic obstructive pulmonary disease; CrCl, creatinine clearance; CS, conventional stent; CX, circumflex artery; DAP, diastolic arterial pressure; DES, drug-eluting stent; Hb, hemoglobin; HR, heart rate; LMCA, left main coronary artery; LVEF, left ventricular ejection fraction; LAD, left anterior descending artery; OWH, out-of-working-hours; WH, working hours; PCI, percutaneous coronary intervention; PCR, polymerase chain reaction; PPCI, primary percutaneous coronary intervention; RC, right coronary artery; SAP, systolic arterial pressure; STEACS, ST–segment-elevation acute coronary syndrome; TIA, transient ischemic attack. Unless otherwise indicated, the data are expressed as no. (%).

The first medical contact took place more often in a hospital that was not equipped with a catheterization laboratory in the OWH PPCI group (20.5% vs 16.5%; P < .001). No differences were found in relation to first contacts through 061 (medical emergency number) or emergency services other than hospital emergency rooms.

There were no significant differences between OWH and WH procedures regarding the time interval between symptom onset and the first medical contact (median, 74 vs 71 minutes; P = .793). The time from the first medical contact to artery-opening treatment was significantly longer in OWH PPCI (median, 128 vs 118 minutes; P < .001). The total ischemia time was longer in OWH PPCI, but this difference did not reach statistical significance (median, 221 vs 211 minutes; P = .094).

After a lengthy follow-up, (median, 1482 [interquartile range, 675-2289] days), there were no differences in mortality or in the other events studied between OWH and WH PPCI (Table 2). OWH PPCI was not associated with a higher adjusted risk of death during follow-up (hazard ratio, 0.92, 95% confidence interval, 0.71-1.19).

Table 2.

Incidence of Clinical Events

Event  At 30 dAt 1 yDuring follow-up (median, 4.06 y)
  WH (n = 756)  OWH (n = 2185)  P  WH (n = 756)  OWH (n = 2185)  P  WH (n = 756)  OWH (n = 2185)  P 
Death  52 (6.9)  121 (5.5)  .179  75 (9.9)  186 (8.5)  .236  106 (14.0)  263 (12.0)  .149 
Re-AMI  18 (2.4)  56 (2.6)  .893  33 (4.4)  97 (4.4)  43 (5.7)  131 (6.0)  .781 
RTV  21 (2.8)  49 (2.2)  .407  44 (5.8)  106 (4.9)  .292  53 (7.0)  141 (6.5)  .551 
ST  16 (2.1)  45 (2.1)  .883  18 (2.4)  55 (2.5)  .893  19 (2.5)  65 (3.0)  .530 

OWH, out-of-working-hours; WH, working hours; n, number of events; Re-AMI, acute myocardial reinfarction; RTV, revascularization of the treated vessel; ST, stent thrombosis. Unless otherwise indicated, the data are expressed as no. (%).

Over the last few years, there has been some controversy regarding the relationship between WH and PPCI-related death. Initial reports described higher mortality rates in OWH procedures,1,2 but this was not seen in more recent studies or in the present series. 3–5 Several explanations have been considered:4 circadian variations in myocardial perfusion, selection bias, and differences in the populations studied or the health care provided. As seen in other studies,2–4 the delays to reperfusion were were longer in OWH than WH PPCI, although the added time yielded a modest absolute value, which could explain why there was no impact of this factor on the clinical outcome. These results should be viewed in the setting of a high-volume hospital providing PPCI within a consolidated regional health care network for STEACS patients6 that offers consistent medical care for infarction in our area, regardless of the time frame. This study has the limitations inherent to a retrospective design based on an unaudited hospital database. In addition, as it did not include patients who were not treated within the publically funded health care system, those who died before PPCI could be performed, and those who could not undergo angioplasty, the series does not necessarily represent the entire population of STEACS patients. Nonetheless, this selection bias is also seen in the other related studies.

Within a network providing care for STEACS patients, OWH PPCI achieves clinical results comparable to those of procedures performed in WH.

References
[1]
J.P.S. Henriques, A.P. Haasdijk, F. Zijlstra.
Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours.
J Am Coll Cardiol., (2003), 41 pp. 2138-3142
[2]
D.J. Magid, Y. Wang, J. Herrin, et al.
Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST–segment elevation myocardial infarction.
JAMA, (2005), 294 pp. 803-812
[3]
H. Jneid, G.C. Fonarow, C.P. Cannon, et al.
Impact of time of presentation on the care and outcomes of acute myocardial infarction.
Circulation., (2008), 117 pp. 2502-2509
[4]
G. Casella, F. Ottani, P. Ortolani, et al.
Off-hour primary percutaneous coronary angioplasty does not affect outcome of patients with ST-segment elevation acute myocardial infarction treated within a regional network for reperfusion: The REAL (Registro Regionale Angioplastiche dell’Emilia-Romagna).
JACC Cardiovasc Interv., (2011), 4 pp. 270-278
[5]
K.S. Rathod, D. Jones, S.M. Gallagher, et al.
Out-of-hours primary percutaneous coronary intervention for ST-elevation myocardial infarction is not associated with excess mortality: a study of 3347 patients treated in an integrated cardiac network.
BMJ Open., (2013), 3 pp. 1-9
[6]
E. Barge-Caballero, J.M. Vazquez-Rodriguez, R. Estevez-Loureiro, et al.
Angioplastia primaria en el Área Norte de Galicia: cambios asistenciales y resultados tras la implantación del programa PROGALIAM.
Rev Esp Cardiol., (2012), 65 pp. 341-349
Copyright © 2017. Sociedad Española de Cardiología
Are you a healthcare professional authorized to prescribe or dispense medications?